Eli Lilly to acquire BIOG portfolio company, AtaiBeckley Inc
. LONDON: Eli Lilly has announced its intention to acquire BIOG portfolio company, AtaiBeckley Inc. for approximately $2.8 billion, or $6.75 a share, in cash representing a 26% premium to AtaiBeckley’s closing price on Wednesday, 15 July 2026, a statement said. The offer…